294 top medical experts on Juvenile Xanthogranuloma across 42 countries and 23 U.S. states, including 171 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Juvenile Xanthogranuloma: Benign disorder of infants and children caused by proliferation of histiocytes, macrophages found in tissues. These histiocytes, usually lipid-laden non-Langerhans cells, form multiple yellow-red nodules most often in the skin, the eye, and sometimes in the viscera. Patients appear to have normal lipid metabolism and are classified as a normolipemic non-Langerhans cell histiocytosis.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Skin Diseases (3,308), Non-Langerhans-Cell Histiocytosis (893).
  4. Clinical Trials ClinicalTrials.gov : at least 3 including 3 Recruiting
  5. Synonyms: Nevoxanthoendothelioma,  Juvenile Xanthoma


  

        

                    


    Computing Expert Listing ...

);